Literature DB >> 30854974

Contribution of the Microbiota to Intestinal Homeostasis and its Role in the Pathogenesis of HIV-1 Infection.

Jorge A Luján1, Maria T Rugeles1, Natalia A Taborda1,2.   

Abstract

During HIV infection, massive destruction of CD4+ T cells ensues, preferentially depleting the Th17 subset at the gut-associated lymphoid tissue (GALT), leading to a loss of mucosal integrity and an increase in cell permeability. This process favors microbial translocation between the intestinal lumen and the circulatory system, contributing to persistent immune activation and chronic inflammation characteristic of HIV infection. Thus, the gut microbiota plays an integral role in maintaining the structure and function of the mucosal barrier, a critical factor for immune homeostasis. However, in the context of HIV infection, changes in the gut microbiota have been reported and have been linked to disease progression. Here, we review evidence for the role of the gut microbiota in intestinal homeostasis, its contribution to HIV pathogenesis, as well as its use in the development of therapeutic strategies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  HIV/AIDS pathogenesis; Microbiota; Th17/Treg axis; dysbiosis; microbial translocation; mucosal immunology.

Mesh:

Year:  2019        PMID: 30854974     DOI: 10.2174/1570162X17666190311114808

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  8 in total

1.  Safety and efficacy of probiotic administration to preterm infants: ten common questions.

Authors:  Mark A Underwood; Erin Umberger; Ravi M Patel
Journal:  Pediatr Res       Date:  2020-08       Impact factor: 3.756

Review 2.  Effect of Opioid Use on Immune Activation and HIV Persistence on ART.

Authors:  Livio Azzoni; David Metzger; Luis J Montaner
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-25       Impact factor: 7.285

3.  Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.

Authors:  Yirui Xie; Jia Sun; Li Wei; Haiyin Jiang; Caiqin Hu; Jiezuan Yang; Ying Huang; Bing Ruan; Biao Zhu
Journal:  BMC Microbiol       Date:  2021-01-06       Impact factor: 3.605

4.  Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes.

Authors:  Giuseppe Ancona; Esther Merlini; Camilla Tincati; Alessandra Barassi; Andrea Calcagno; Matteo Augello; Valeria Bono; Francesca Bai; Elvira S Cannizzo; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.

Authors:  Edda Russo; Giulia Nannini; Gaetana Sterrantino; Seble Tekle Kiros; Vincenzo Di Pilato; Marco Coppi; Simone Baldi; Elena Niccolai; Federica Ricci; Matteo Ramazzotti; Marco Pallecchi; Filippo Lagi; Gian Maria Rossolini; Alessandro Bartoloni; Gianluca Bartolucci; Amedeo Amedei
Journal:  World J Gastroenterol       Date:  2022-02-14       Impact factor: 5.374

6.  A specific structure and high richness characterize intestinal microbiota of HIV-exposed seronegative individuals.

Authors:  Tulio J Lopera; Jorge A Lujan; Eduardo Zurek; Wildeman Zapata; Juan C Hernandez; Miguel A Toro; Juan F Alzate; Natalia A Taborda; Maria T Rugeles; Wbeimar Aguilar-Jimenez
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 7.  Colostrum Therapy for Human Gastrointestinal Health and Disease.

Authors:  Kanta Chandwe; Paul Kelly
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

8.  Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM.

Authors:  Yue Chen; Huang Lin; Mariah Cole; Alison Morris; Jeremy Martinson; Heather Mckay; Matthew Mimiaga; Joseph Margolick; Adam Fitch; Barbara Methe; Vatsala Rangachar Srinivas; Shyamal Peddada; Charles R Rinaldo
Journal:  Microbiome       Date:  2021-12-09       Impact factor: 14.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.